Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study.
about
Recent advances in oocyte and ovarian tissue cryopreservation and transplantationSurgical Aspects of Ovarian Tissue Removal and Ovarian Tissue Transplantation for Fertility PreservationIncidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.Emerging gonadotropin-releasing hormone agonists.Fertility preservation in young cancer patients.The physiology and clinical utility of anti-Mullerian hormone in women.86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children.Management of fertility in patients treated for Hodgkin's lymphoma.Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation.Safety of ovarian tissue autotransplantation for cancer patients.The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature.Evidence-Based Recommendations for Fertility Preservation Options for Inclusion in Treatment Protocols for Pediatric and Adolescent Patients Diagnosed With Cancer.Transplantation of female genital organs.Fertility conservation in breast cancer patients.Cryopreservation of ovarian tissue for fertility preservation in young female oncological patients.Anti-Müllerian hormone and assessment of ovarian reserve after ovarian toxic treatment: a systematic narrative review.Operative techniques and complications of extraction and transplantation of ovarian tissue: the Erlangen experience.Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives.The proteolytic activity of pregnancy-associated plasma protein-A is potentially regulated by stanniocalcin-1 and -2 during human ovarian follicle development.Cryopreservation of ovarian tissue for fertility preservation in a large cohort of young girls: focus on pubertal development.Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation.The effect of repeated administration of methotrexate (MTX) on rat ovary: measurement of serum antimullerian hormone (AMH) levels.Fertility preservation in >1,000 patients: patient's characteristics, spectrum, efficacy and risks of applied preservation techniques.Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.The influence of unilateral oophorectomy on the age of menopause.Letter in reply to "Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations".Fertility preservation before an ABVD protocol: no new evidence to support changing the recommendations.Outcomes of transplantations of cryopreserved ovarian tissue to 41 women in Denmark.
P2860
Q27015937-1510D9A2-4495-4C65-9529-D2D45C883D63Q28071283-2438B08A-B278-4FCE-A2FC-AB72AEBDAD77Q33601886-54AAE89F-ADC4-43BC-B6F2-A4CFDB63BE34Q33796122-0E76A330-C573-4BFF-BB20-E2D120116083Q33935418-63323972-A938-4A5E-A920-F2F07174B027Q34398233-BEA36C77-701D-40DF-8776-83075C159996Q34548143-F44EE0AA-B77B-42E1-A0CA-BB5385473D0CQ35528686-4DE95F3F-311E-4E0E-8704-BF5518007A25Q35621478-2D47D6B6-ACF3-486F-80CC-42902D4B42BAQ35664382-01DB091C-7072-49D7-8747-657BA4601037Q36557304-DDFE7141-BDE0-48C5-AFE6-3D6614C47F58Q37557863-519B1D20-4AE6-425C-83D5-631D435C4C39Q37846883-C53199B4-2F03-46CC-A577-140D1E171CC6Q37853557-11120994-C263-4806-8E67-ACE7908B2691Q38014535-ABBA961A-4B48-4BBB-8D21-54A3F5ABA719Q38250303-E0F17CFA-A869-4858-8A55-314D2CCCB539Q38757529-E071941C-D630-492E-8A95-7A13A745091EQ38824459-6731906F-9E98-4A4F-8264-53E7F66ABDAEQ38908472-F57B4AB8-28C0-4AEA-9649-29D3A5414694Q39212047-310275E3-0277-4D56-BE12-87FA0A99C778Q39974283-032E9C81-6044-4505-B4BB-61264654B78DQ44308980-CD58AAAB-6E08-4BC2-BF01-895742EC768AQ46590938-7B5E9CD5-F873-4550-AFFC-8B60E5A49648Q47853555-3C3696B1-8D2D-4C93-BC50-AF2E117FE37CQ47949149-97258DFF-42A2-41B7-A226-90549BF9E06CQ48067359-3A486361-A2B0-43CD-8BD5-22A6D0A35065Q48067572-10E3E24F-07F9-4EBB-9366-B2CBD4082E0FQ50568592-F24967BB-E6C4-4E37-8E3D-4793BEA9D75C
P2860
Ovarian function after removal of an entire ovary for cryopreservation of pieces of cortex prior to gonadotoxic treatment: a follow-up study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Ovarian function after removal ...... treatment: a follow-up study.
@en
Ovarian function after removal ...... treatment: a follow-up study.
@nl
type
label
Ovarian function after removal ...... treatment: a follow-up study.
@en
Ovarian function after removal ...... treatment: a follow-up study.
@nl
prefLabel
Ovarian function after removal ...... treatment: a follow-up study.
@en
Ovarian function after removal ...... treatment: a follow-up study.
@nl
P2093
P356
P1433
P1476
Ovarian function after removal ...... treatment: a follow-up study.
@en
P2093
Anders Nyboe Andersen
Erik Ernst
Lars G Westergaard
Per Emil Rasmussen
P304
P356
10.1093/HUMREP/DEN248
P407
P577
2008-07-17T00:00:00Z